Khabre branded placeholder image

health

Preprint finds insulin-binding B cells in early-stage type 1 diabetes

A bioRxiv preprint reports insulin-binding B cells in people with stage 1 and stage 2 type 1 diabetes, including some without detectable insulin autoantibodies. The findings suggest that antibody tests alone may miss some insulin-directed immune activity.

Khabre branded placeholder image

health

Long COVID preprint finds activated virus-specific T cells

A bioRxiv preprint reports elevated activation in virus-specific CD8 T cells from a subset of people with long COVID. The immune-cell profiles are consistent with persistent antigen stimulation, but provide an indirect signal rather than direct detection of viral antigens.

Khabre branded placeholder image

health

TFAM insufficiency links lung inflammation to weaker flu memory in mice

A bioRxiv preprint reports that TFAM-insufficient CD8⁺ T cells in influenza-infected mice were associated with lung immunopathology and weaker later immune responses, without improved viral control. The researchers also observed age-associated declines in TFAM expression and mitochondrial function in human CD8⁺ T cells.

Khabre branded placeholder image

health

Lupus preprint finds anti-SDMA antibodies in 30–40% of patients

A bioRxiv preprint reports anti-SDMA autoantibodies in 30–40% of people with systemic lupus erythematosus. In a separate validation cohort of 201 patients, antibody levels correlated with disease-activity scores and complement levels.

Khabre branded placeholder image

health

Preprint identifies how an anti-HPA-1a antibody activates platelets

A bioRxiv preprint describes two patient-derived anti-HPA-1a antibodies and finds that one induced platelet aggregation through coordinated binding to HPA-1a and FcγRIIa. The laboratory study provides a mechanistic explanation for functional differences among antibodies involved in fetal and neonatal alloimmune thrombocytopenia.

Khabre branded placeholder image

health

Preprint describes targeted IL-2 fusion for inflamed tissue

A bioRxiv preprint describes IL-2IT, a bispecific fusion protein designed to carry IL-2 to oxidation-specific epitopes at inflamed sites. In laboratory and in vivo models, the treatment showed greater Treg selectivity and benefits in psoriasis, colitis and atherosclerosis models.